The CCR2/CCL2 Interaction Mediates the Transendothelial Recruitment of Intravascularly Delivered Neural Stem Cells to the Ischemic Brain

Abstract

Background and Purpose The inflammatory response is a critical component of ischemic stroke. In addition to its physiological role, the mechanisms behind transendothelial recruitment of immune cells also offer a unique therapeutic opportunity for translational stem cell therapies. Recent reports have demonstrated homing of neural stem cells (NSC) into the injured brain areas after intravascular delivery. However, the mechanisms underlying the process of transendothelial recruitment remain largely unknown. Here we describe the critical role of the chemokine CCL2 and its receptor CCR2 in targeted homing of NSC after ischemia. Methods Twenty-four hours after induction of stroke using the hypoxia-ischemia model in mice CCR2+/+ and CCR2−/− reporter NSC were intra-arterially delivered. Histology and bioluminescence imaging were used to investigate NSC homing to the ischemic brain. Functional outcome was assessed with the horizontal ladder test. Results Using NSC isolated from CCR2+/+ and CCR2−/− mice, we show that receptor deficiency significantly impaired transendothelial diapedesis specifically in response to CCL2. Accordingly, wild-type NSC injected into CCL2−/− mice exhibited significantly decreased homing. Bioluminescence imaging showed robust recruitment of CCR2+/+ cells within 6 hours after transplantation in contrast to CCR2−/− cells. Mice receiving CCR2+/+ grafts after ischemic injury showed a significantly improved recovery of neurological deficits as compared to animals with transplantation of CCR2−/− NSC. Conclusions The CCL2/CCR2 interaction is critical for transendothelial recruitment of intravascularly delivered NSC in response to ischemic injury. This finding could have significant implications in advancing minimally invasive intravascular therapeutics for regenerative medicine or cell-based drug delivery systems for central nervous system diseases.

Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury

“…Transfection experiments were performed using the NeuroPORTER transfection kit (Sigma-Aldrich) following a previously published protocol with modifications (Di Giovanni et al, 2005;Uchida et al, 2006;Chi and Nicol, 2007;Andres et al, 2011). The cells were rinsed once with Opti-MEM medium and incubated at 37°C for ϳ30 min.…”

How stem cells speak with host immune cells in inflammatory brain diseases

“…• The activation of monocyte chemoattractant protein (MCP)-1/CCL2 signaling plays a central role in the transendothelial recruitment of intra-arterially delivered (CCR2-expressing) mouse NPCs in vivo (Andres et al, 2011), although it is not functional on human MSCs (Ringe et al, 2007);…”

Neurotherapeutic Effect of Cord Blood Derived CD45+Hematopoietic Cells in Mice after Traumatic Brain Injury

“…These findings are consistent with many studies indicating homing ability of IV-infused stem cells to the site of injury, 45 although a majority of these cells will end up in the lung, spleen, stomach, and small and large intestines. 46 Disruption of the blood brain-barrier, which occurs rapidly (within 1-4 h after injury), 4,5 and other mechanisms promoting homing to the injury site, 47 are probably involved in the enhanced homing to and engraftment in the injured brain, in particular at the site of lesion and its close vicinity. Our finding of rapid homing of intravenously-administered HUCB-derived MNCs and CD45 + cells to the injured site is in line with previous reports tracking the integration of bone marrowderived MSCs into traumatic injured brain.…”